Pictet Asset Management (Switzerland)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Pictet Asset Management (Switzerland)'s PFE Position: Q2 2023 in Review
Pictet Asset Management (Switzerland) increased its Pfizer (PFE) stake by 4.3% in Q2 2023, buying an estimated $4.03M and bringing the position to 2,518,887 shares worth $92.4M. The position accounts for 0.11% of the portfolio, ranked #206.
Pictet Asset Management (Switzerland) first reported a position in PFE in Q3 2021 and has held it in 8 quarters since. The position peaked at $182M in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Pictet Asset Management (Switzerland) held 2,518,887 shares of Pfizer worth $92.4M as of Q2 2023.
- Pictet Asset Management (Switzerland) bought 103,611 Pfizer shares in Q2 2023, an estimated $4.03M.
- Pfizer made up 0.11% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #206 holding.
- Pictet Asset Management (Switzerland) first reported a position in Pfizer in Q3 2021 and has held it in 8 quarters since.
- Pictet Asset Management (Switzerland)'s Pfizer position peaked at $182M in Q4 2021.
- 3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.